Literature DB >> 9541446

Comparison of Fucithalmic viscous eye drops and Chloramphenicol eye ointment as a single treatment in corneal abrasion.

G Boberg-Ans1, K R Nissen.   

Abstract

PURPOSE: To compare the healing of the cornea and the incidence of infection after traumatic corneal epithelial defect after single treatment with double bandage combined with either Fucithalmic single unit dose eye drops or chloramphenicol eye ointment.
METHODS: This is a single-centre, randomised, single-blind, parallel-group study of 144 patients with accidental corneal abrasion or corpus alieni cornea who were referred to the Eye Department at Gentofte Hospital. The injured eye was examined with a photo slit-lamp before and 24 hours after treatment. The size of the abrasion was recorded and calculated on a PCX computerized video system and by slit-lamp photography. RESULTS &
CONCLUSION: The Fucithalmic and chloramphenicol ointment treated groups showed no significant difference in corneal healing, local side effects, or signs of local infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541446     DOI: 10.1034/j.1600-0420.1998.760121.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  An audit of corneal abrasion management following the introduction of local guidelines in an accident and emergency department.

Authors:  S K Thyagarajan; V Sharma; S Austin; T Lasoye; P Hunter
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

Review 2.  Antibiotic prophylaxis for corneal abrasion.

Authors:  Abdullah M Algarni; Gordon H Guyatt; Angus Turner; Saad Alamri
Journal:  Cochrane Database Syst Rev       Date:  2022-05-27

Review 3.  Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.

Authors:  T Y Y Lai; V W Y Wong; G M Leung
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

Review 4.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.